Navigation Links
First human trial of antibacterial contact lens

Biotechnology company Biosignal Ltd and the Institute for Eye Research have received ethics approval for the first human clinical trial of an antibacterial extended-wear contact lens.

The ASX-listed company commercialises a novel anti-bacterial technology identified by UNSW researchers at the Centre for Marine Biofouling and Bioinnovation.

The trial beginning on June 29 will compare the safety performance of an antibacterial contact lens to that of a standard contact lens.

The comparison involving ten people will evaluate eye health, lens performance on the eye and wearers' subjective responses. Biosignal will announce the trial's results to the market in July.

"Adverse events caused by microbial contamination of contact lenses are a major impediment to more convenient, extended wear of contact lenses," says UNSW Professor Mark Willcox, who will supervise the trial. "This trial is the first significant step towards overcoming this significant problem."

Acute red eye occurs in 20 per cent per year of the estimated 100 million wearers of contact lenses worldwide. Microbial keratitis, a serous eye disease that can cause blindness, occurs in one in 500 contact lens wearers per year if they sleep in lenses. There is currently no antibacterial contact lens in the market.

Biosignal's technology prevents and disrupts microbial infection by "jamming" the signalling systems bacteria rely on to form biofilms. Because the technology does not kill bacteria, Biosignal's technology is less likely to create the drug-resistance problems that plague current anti-microbial treatments. The US Centers for Disease Control estimate that biofilms account for at least two-thirds of all chronic bacterial infections.

Biosignal and the Institute for Eye Research have tested antibiofilm compounds and generated proof of concept data in a broad range of product categories in the medical, industrial and consumer fields.


'"/>

Source:University of New South Wales


Related biology news :

1. Timing is everything: First step in protein building revealed
2. Emory Eye Center Implants Its First Retinal Chips In Patients With Retinitis Pigmentosa
3. First atlas of key brain genes could speed research on cancer, neurological diseases
4. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
5. NYCs First Rapid HIV Drug-resistant AIDS Case Prompts Call to Step Up HIV Prevention
6. First real-time view of developing neurons reveals surprises, say Stanford researchers
7. Breast-Cancer Risk Linked to Exposure to Traffic Emissions at Menarche, First Birth
8. Mayo Clinic Researchers Create Obedient Virus; First Step To Use Measles Virus Against Cancer
9. First frozen egg baby born in Canada
10. Human Cells Filmed Instantly Messaging for First Time
11. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2017)... TEANECK, N.J. , May 16, 2017  Veratad ... leading provider of online age and identity verification solutions, ... the K(NO)W Identity Conference 2017, May 15 thru May ... Ronald Regan Building and International Trade Center. ... across the globe and in today,s quickly evolving digital ...
(Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
(Date:4/17/2017)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... 2016 Annual Report on Form 10-K on Thursday April 13, 2017 ... ... Investor Relations section of the Company,s website at http://www.nxt-id.com  under ... http://www.sec.gov . 2016 Year Highlights: ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... The Blavatnik ... Winners and six Finalists of the 2017 Blavatnik Regional Awards for Young Scientists. ... Foundation and administered by the New York Academy of Sciences to honor the ...
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS ... the addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US ... absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. ...
(Date:10/11/2017)... ... October 11, 2017 , ... At its ... announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist of ... been selected for membership in ARCS Alumni Hall of Fame . ASTER ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit ... 7th and 8th June 2018 in San Francisco, CA. The Summit brings together current ... several distinguished CEOs, board directors and government officials from around the world to address ...
Breaking Biology Technology: